Serotonin transporter gene and schizophrenia : evidence for association/linkage disequilibrium in families with affected siblings

The serotonergic (5-HT) system has been implicated in the etiopathogenesis of psychoses. Since the 5-HT transporter plays an important role in regulation of 5-HT transmission, its gene can be considered as a candidate for vulnerability to psychiatric disorders. Two polymorphic sites of the 5-HT tran...

Full description

Saved in:
Bibliographic Details
Published inMolecular psychiatry Vol. 5; no. 1; pp. 91 - 95
Main Authors HRANILOVIC, D, SCHWAB, S. G, MAIER, W, WILDENAUER, D. B, JERNEJ, B, KNAPP, M, LERER, B, ALBUS, M, RIETSCHEL, M, KANYAS, K, BORRMANN, M, LICHTERMANN, D
Format Journal Article
LanguageEnglish
Published Basingstoke Nature Publishing Group 2000
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The serotonergic (5-HT) system has been implicated in the etiopathogenesis of psychoses. Since the 5-HT transporter plays an important role in regulation of 5-HT transmission, its gene can be considered as a candidate for vulnerability to psychiatric disorders. Two polymorphic sites of the 5-HT transporter gene-5-HTTLPR, a VNTR in the 5' regulatory region, and a VNTR in the second intron-were studied in a sample of 61 families with schizophrenia for transmission disequilibrium. Each family contained at least two siblings affected with schizophrenia or schizoaffective disorder (mainly schizophrenic). One hundred and thirty-nine affected offspring with parental information for genotyping, were available for analysis. No preferential transmission of either short or long alleles of the promoter polymorphism was observed. However, a transmission distortion was detected for alleles of the intronic VNTR polymorphism (chi2TDT max =14.33; P = 0.0002; corrected P value = 0.0003) resulting in more frequent than expected transmission of the 12 repeat allele. This finding adds additional evidence to the idea that the serotonergic system may be involved in development of psychoses. Molecular Psychiatry (2000) 5, 91-95.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:1359-4184
1476-5578
DOI:10.1038/sj.mp.4000599